4D Molecular Therapeutics (FDMT) Other Gross PP&E Adjustments: 2019-2025
Historic Other Gross PP&E Adjustments for 4D Molecular Therapeutics (FDMT) over the last 5 years, with Sep 2025 value amounting to $13.1 million.
- 4D Molecular Therapeutics' Other Gross PP&E Adjustments rose 16.08% to $13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.4 million, marking a year-over-year decrease of 25.81%. This contributed to the annual value of $12.4 million for FY2024, which is 34.67% down from last year.
- Latest data reveals that 4D Molecular Therapeutics reported Other Gross PP&E Adjustments of $13.1 million as of Q3 2025, which was down 3.63% from $13.6 million recorded in Q2 2025.
- 4D Molecular Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $20.4 million for Q2 2024, and its period low was $3.6 million during Q4 2021.
- In the last 3 years, 4D Molecular Therapeutics' Other Gross PP&E Adjustments had a median value of $16.6 million in 2023 and averaged $15.9 million.
- Per our database at Business Quant, 4D Molecular Therapeutics' Other Gross PP&E Adjustments skyrocketed by 331.75% in 2022 and then slumped by 35.68% in 2024.
- Over the past 5 years, 4D Molecular Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $3.6 million in 2021, then spiked by 331.75% to $15.5 million in 2022, then grew by 22.49% to $18.9 million in 2023, then tumbled by 34.67% to $12.4 million in 2024, then increased by 16.08% to $13.1 million in 2025.
- Its last three reported values are $13.1 million in Q3 2025, $13.6 million for Q2 2025, and $13.3 million during Q1 2025.